Evogene (EVGN) Reports Q2 Loss of $0.31/Share

Evogene (NYSE: EVGN) reported Q2 EPS of ($0.31), versus ($0.33) reported last year. Revenue for the quarter came in at $3.82 million, versus $5.36 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• Methanex (MEOH) Tops Q1 EPS by 35c
• ChampionX (CHX) Tops Q1 EPS by 8c